There are few women that are changing the world of medicine and science the way JeanMarie Guenot has in the past several years. JeanMarie Guenot has over 20 years of biotechnology and pharmaceutical experience. She has worked at private companies and public, in all stages of their business. JeanMarie Guenot has worked mostly in pharmaceutical research and development, business development, commercial and corporate development, venture capital and project and alliance management. Dr. Jeanmarie Guenot has extensive experience in building and rebuilding companies. She is currently the Chief Executive Officer and President of Amphivena Therapeutics, Inc. Amphivena Therapeutics, Inc is a company that develops bifunctional antibody therapies for various types of cancer. Prior to being the Chief Executive Officer and President of Amphivena Therapeutics, Ms. Guenot was the founder of SKS Ocular. She built SKS Ocular from the ground up. SKS Ocular started as an ophthalmic company incubator. The company specialized in sustained release ocular drug delivery technology, therapy for glaucoma, and additional therapies for ocular inflammation and macular degeneration.
At Hoffmann-La Roche, Dr. Guenot was an advisor for their Shanghai and Basel offices. She was the Vice President of a company called PDL Bio Pharma, where she was in charge of corporate and business development on takeda.com. At PDL Bio Pharma, she was also in charge of the licensing, alliance management, mergers and acquisitions, and product portfolios. Dr. Guenot is trained in medical and physical chemistry and she focuses on semi-empirical and quantum mechanical methods.
Dr. Guenot’s career in business began at Atlas Venture. At Atlas Venture, she was responsible for venture capital investments and life science companies at http://amphivena.com/amphivena_leaders/jeanmarie-guenot-ph-d/. As a scientist, she started her career at Hoffmann-La Roche in Preclinical Research and Development. She was the principal scientist at the company. Dr. Guenot received her Ph.D. from the University of California – San Francisco. She also received her Master’s from The Wharton School.